Cargando…
Efficacy and safety of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis
OBJECTIVE: This study aims to determine the efficacy and safety of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients. METHODS: We searched Cochrane Library, PubMed, Embase, and ClinicalTrials.gov databases until July 27, 2022. Both randomized control trials (R...
Autores principales: | Xi, An-ran, Luo, Yi-jun, Guan, Jin-Tao, Wang, Wei-Jie, Xu, Zheng-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707187/ https://www.ncbi.nlm.nih.gov/pubmed/36445552 http://dx.doi.org/10.1007/s10787-022-01105-9 |
Ejemplares similares
-
A meta-analysis of granulocyte-macrophage colony-stimulating factor
(GM-CSF) antibody treatment for COVID-19 patients
por: Guan, Jin-Tao, et al.
Publicado: (2021) -
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
por: Bo, Lulong, et al.
Publicado: (2011) -
Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’
por: Guan, Jin-Tao, et al.
Publicado: (2021) -
The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease
por: Jones, Thomas C.
Publicado: (1996) -
Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease
por: Cook, Andrew D, et al.
Publicado: (2001)